These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1702564)

  • 21. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
    Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
    J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
    Collins L; Franzblau SG
    Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis.
    Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W
    Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ethionamide sensitivity of East African strains of Mycobacterium tuberculosis resistant to thiacetazone.
    Lefford MJ
    Tubercle; 1969 Mar; 50(1):7-13. PubMed ID: 4181091
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
    Steadham JE; Stall SK; Simmank JL
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basic research of thiacetazone in the treatment of tuberculosis. I. Susceptibility of tubercle bacilli isolated from pulmonary tuberculosis patients to thiacetazone].
    Gao DZ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Jun; 6(3):171-3. PubMed ID: 6197264
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Gay JD; DeYoung DR; Roberts GD
    Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex.
    Johnson SM; Roberts GD
    Diagn Microbiol Infect Dis; 1987 May; 7(1):89-91. PubMed ID: 3121243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity to thiacetazone and para-aminosalicylic acid and the virulence in the guinea pig of East African strains of Mycobacterium tuberculosis.
    Lefford MJ; Dickinson JM; Mitchison DA
    Tubercle; 1969 Mar; 50(1):1-6. PubMed ID: 4181090
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thiacetazone sensitivity of Mycobacterium tuberculosis.
    Cavanagh P; McPherson K
    J Med Microbiol; 1969 Aug; 2(3):237-42. PubMed ID: 4102264
    [No Abstract]   [Full Text] [Related]  

  • 37. Is pyrazinamide bactericidal against Mycobacterium tuberculosis?
    Heifets LB; Lindholm-Levy PJ
    Am Rev Respir Dis; 1990 Jan; 141(1):250-2. PubMed ID: 2105072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex].
    Yamamoto T; Amitani R; Kuze F; Suzuki K
    Kekkaku; 1990 Dec; 65(12):805-10. PubMed ID: 2127615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of antimycobacterial activity of a series of mainly marine derived natural products.
    König GM; Wright AD; Franzblau SG
    Planta Med; 2000 May; 66(4):337-42. PubMed ID: 10865450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.